Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Helius Medical Tech (NASDAQ:HSDT) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Helius Medical Tech beat estimated earnings by 61.0%, reporting an EPS of $-1.47 versus an estimate of $-3.77.
Revenue was down $148 thousand from the same period last year.
Last quarter the company beat on EPS by $0.51 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Helius Medical Tech's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -6 | -6 | -5.5 | -6.5 |
EPS Actual | -5.49 | -3 | -4.5 | -8.5 |
Revenue Estimate | 340K | 190K | 280K | 260K |
Revenue Actual | 143K | 256K | 111K | 282K |
To track all earnings releases for Helius Medical Tech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: HSDT